NeurosciencebioRxivPreprint
Deletion or Targeted Blockade of FcγRIIb (CD32b) Impairs α-Syn Propagation In-Vivo
James M. Hennegan, Michael J. Hurley, Kerry L. Cox…·Jessica L. Teeling
This study shows that FcγRIIb promotes α-syn propagation and neurotoxicity in vivo, suggesting it as a therapeutic target for synucleinopathies.
DOI 10.1101/2025.11.18.687143